359 related articles for article (PubMed ID: 26416214)
1. Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA).
Eggers M; Eickmann M; Zorn J
Infect Dis Ther; 2015 Dec; 4(4):491-501. PubMed ID: 26416214
[TBL] [Abstract][Full Text] [Related]
2. Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses.
Eggers M; Eickmann M; Kowalski K; Zorn J; Reimer K
BMC Infect Dis; 2015 Sep; 15():375. PubMed ID: 26381737
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens.
Eggers M; Koburger-Janssen T; Eickmann M; Zorn J
Infect Dis Ther; 2018 Jun; 7(2):249-259. PubMed ID: 29633177
[TBL] [Abstract][Full Text] [Related]
4. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.
Anderson DE; Sivalingam V; Kang AEZ; Ananthanarayanan A; Arumugam H; Jenkins TM; Hadjiat Y; Eggers M
Infect Dis Ther; 2020 Sep; 9(3):669-675. PubMed ID: 32643111
[TBL] [Abstract][Full Text] [Related]
5. In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice.
Hassandarvish P; Tiong V; Mohamed NA; Arumugam H; Ananthanarayanan A; Qasuri M; Hadjiat Y; Abubakar S
Br Dent J; 2020 Dec; ():1-4. PubMed ID: 33303923
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
Veit S; Jany S; Fux R; Sutter G; Volz A
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal and Virucidal Activity of Povidone-Iodine and Chlorhexidine Gluconate Cleansers in an In Vivo Hand Hygiene Clinical Simulation Study.
Eggers M; Koburger-Janssen T; Ward LS; Newby C; Müller S
Infect Dis Ther; 2018 Jun; 7(2):235-247. PubMed ID: 29761329
[TBL] [Abstract][Full Text] [Related]
8. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
[TBL] [Abstract][Full Text] [Related]
9. Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update.
Chopra A; Sivaraman K; Radhakrishnan R; Balakrishnan D; Narayana A
Jpn Dent Sci Rev; 2021 Nov; 57():39-45. PubMed ID: 33747261
[TBL] [Abstract][Full Text] [Related]
10. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
[TBL] [Abstract][Full Text] [Related]
11. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
Haagmans BL; van den Brand JM; Raj VS; Volz A; Wohlsein P; Smits SL; Schipper D; Bestebroer TM; Okba N; Fux R; Bensaid A; Solanes Foz D; Kuiken T; Baumgärtner W; Segalés J; Sutter G; Osterhaus AD
Science; 2016 Jan; 351(6268):77-81. PubMed ID: 26678878
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses.
Shet M; Hong R; Igo D; Cataldo M; Bhaskar S
Infect Dis Ther; 2021 Dec; 10(4):2777-2790. PubMed ID: 34581973
[TBL] [Abstract][Full Text] [Related]
13. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.
Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
15. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
16. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of various gargle formulations and salt water against SARS-CoV-2.
Tiong V; Hassandarvish P; Bakar SA; Mohamed NA; Wan Sulaiman WS; Baharom N; Abdul Samad FN; Isahak I
Sci Rep; 2021 Oct; 11(1):20502. PubMed ID: 34654867
[TBL] [Abstract][Full Text] [Related]
18. Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein.
Raadsen MP; Dahlke C; Fathi A; Lamers MM; van den Doel P; Zaeck LM; van Royen ME; de Bruin E; Sikkema R; Koopmans M; van Gorp ECM; Sutter G; de Vries RD; Addo MM; Haagmans BL
J Infect Dis; 2023 Aug; 228(5):586-590. PubMed ID: 36857443
[TBL] [Abstract][Full Text] [Related]
19. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.
Weskamm LM; Fathi A; Raadsen MP; Mykytyn AZ; Koch T; Spohn M; Friedrich M; ; Haagmans BL; Becker S; Sutter G; Dahlke C; Addo MM
Cell Rep Med; 2022 Jul; 3(7):100685. PubMed ID: 35858586
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4.
Haverkamp AK; Lehmbecker A; Spitzbarth I; Widagdo W; Haagmans BL; Segalés J; Vergara-Alert J; Bensaid A; van den Brand JMA; Osterhaus ADME; Baumgärtner W
Sci Rep; 2018 Jun; 8(1):9778. PubMed ID: 29950581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
